Does Rallies show Form 4 insider transactions for TOI?

Yes. Rallies tracks TOI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is TOI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TOI. It does not provide personalized investment advice.

TOI (The Oncology Institute, Inc. Common Stock) Stock Analysis - Insider Trades

The Oncology Institute, Inc. Common Stock (TOI) is a publicly traded Healthcare sector company. As of May 21, 2026, TOI trades at $4.17 with a market cap of $399.93M and a P/E ratio of -11.64. TOI moved +2.32% today. Year to date, TOI is +7.14%; over the trailing twelve months it is +51.08%. Its 52-week range spans $0.13 to $4.88. Analyst consensus is strong buy with an average price target of $7.00. Rallies surfaces TOI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading TOI stock inside the company?

Recent TOI insider activity includes Chernett Jorey bought 30.00K, Kaushal Mohit sold 38.43K, Kaushal Mohit sold 57.29K, Chernett Jorey bought 20.00K, and Chernett Jorey bought 27.43K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

TOI Key Metrics

Key financial metrics for TOI
Metric	Value
Price	$4.17
Market Cap	$399.93M
P/E Ratio	-11.64
EPS	$-0.35
Dividend Yield	0.00%
52-Week High	$4.88
52-Week Low	$0.13
Volume	1.27K
Avg Volume	0
Revenue (TTM)	$545.76M
Net Income	$-43.51M
Gross Margin	0.00%

Recent TOI Insider Trades

Chernett Jorey bought 30.00K (~$122.70K) on May 19, 2026.
Kaushal Mohit sold 38.43K (~$134.53K) on Apr 16, 2026.
Kaushal Mohit sold 57.29K (~$200.60K) on Apr 14, 2026.
Chernett Jorey bought 20.00K (~$62.00K) on Apr 9, 2026.
Chernett Jorey bought 27.43K (~$81.19K) on Mar 27, 2026.

Latest TOI News

Oncology Institute Guides Q1 Revenue $143.23M, Raises Full-Year Estimate to $647.84M — May 6, 2026
Oncology Institute Achieves First Profit, Grows Revenue 28% to $500M+ — Mar 13, 2026
Oncology Institute Forecasts Q4 Revenue $139.8M, EPS –$0.09; 2026 Revenue Raised — Mar 11, 2026

TOI Analyst Consensus

4 analysts cover TOI: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.00.

Common questions about TOI

Who is trading TOI stock inside the company?: Recent TOI insider activity includes Chernett Jorey bought 30.00K, Kaushal Mohit sold 38.43K, Kaushal Mohit sold 57.29K, Chernett Jorey bought 20.00K, and Chernett Jorey bought 27.43K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for TOI?: Yes. Rallies tracks TOI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is TOI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TOI. It does not provide personalized investment advice.